Work

Efficacy and Safety of 1500 mg Voxelotor in a Phase 2a Study (GBT440-007) in Adolescents with Sickle Cell Disease

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-117510

Authors: Clark Brown, Carolyn Hoppe, Adlette Inati, Miguel R. Abboud, Winfred Wang, Robert Liem, Gerald Woods, Lewis L. Hsu, Victor R. Gordeuk, Connie Piccone, Richard A. Drachtman, Erica Fong, Sandra Dixon, Margaret Tonda, Carla Washington, Joshua Lehrer-Graiwer

Institutions: Children's Healthcare of Atlanta, UCSF Benioff Children's Hospital, Rafik Hariri University Hospital, American University of Beirut Medical Center, St. Jude Children's Research Hospital, Lurie Children's Hospital, Children's Mercy Hospital, University of Illinois Chicago, Rainbow Babies & Children's Hospital, Rutgers Cancer Institute, Global Blood Therapeutics (United States)

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2906922470

Cites:

Cited by: 4

Related to: 10